Related Experiment Video

Updated: Aug 31, 2025

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

19.7K

Neonatal BCG: a time for change

Thillagavathie Pillay1,2, Gergely Toldi3, Abid Hussain4

  • 1Neonatology, University Hospitals of Leicester NHS Trust, Leicester, UK tilly.pillay@uhl-tr.nhs.uk.

Archives of Disease in Childhood. Education and Practice Edition
|August 25, 2022
PubMed

Insights

The UK's Bacillus Calmette-Guérin (BCG) vaccination for babies is now recommended at 28 days after birth. This change may impact vaccination uptake due to potential barriers.

Area of Science:

  • Immunology
  • Public Health

Background:

  • The UK's Bacillus Calmette-Guérin (BCG) vaccination program is typically risk-based and administered shortly after birth.
  • Recent guidance from the Joint Committee on Vaccination and Immunisation has altered the recommended timing.

Purpose of the Study:

  • To highlight the revised timing of the BCG vaccination in the UK.
  • To discuss the rationale behind this change.
  • To identify potential barriers to BCG uptake associated with the new schedule.

Main Methods:

  • Review of recent guidance from the Joint Committee on Vaccination and Immunisation.
  • Analysis of the implications of the revised vaccination schedule.

Main Results:

  • The BCG vaccination is now recommended at 28 days after birth or soon thereafter.
  • The rationale for this change is based on updated immunisation advice.

Conclusions:

  • The revised timing of the BCG vaccination program presents potential challenges for uptake.
  • Understanding and addressing these barriers is crucial for maintaining vaccination coverage.

Keywords:
allergy and immunologycommunicable diseasesinfectious disease medicineneonatologypaediatrics

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

6.5K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.7K

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
426
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
218